The Hidden Reality of Skin Care: New Data Reveals a Massive Care Gap

DENVER – March 26, 2026 – A vast and largely invisible world of healthcare is unfolding in homes across the country, and it has little to do with doctors' offices or prescriptions. New research reveals that for chronic skin conditions like acne and psoriasis, the majority of patient care happens through self-management, over-the-counter products, and personal research—far from the watchful eyes of clinicians. This gap between the clinic and real life represents a massive blind spot for the healthcare industry, one that health research leader Evidation is now seeking to illuminate.

Preliminary insights from a massive survey of over 78,000 individuals paint a stark picture: the way patients actually manage their skin is fundamentally misunderstood by a system that relies on claims and electronic health records. The findings suggest that the true burden of these conditions, and the complex journeys patients navigate, have remained largely unmeasured until now.

The Invisible Patient Journey

The data, shared by Evidation, exposes a significant disconnect between patients and the formal healthcare system. According to the company's preliminary findings, approximately 70% of individuals with acne and psoriasis are likely underrepresented in traditional healthcare data simply because they have little to no engagement with providers.

The numbers are striking. Among individuals with acne, a staggering 80% reported not seeking care from a dermatologist or any other healthcare provider in the past year. The situation is similar for those with psoriasis, a chronic autoimmune disease; 65% of those surveyed who reported a diagnosis said they were not seeing a specialist for ongoing management.

Instead of clinical oversight, these individuals are creating their own care pathways. The research shows that many psoriasis patients turn to over-the-counter (OTC) treatments (23%) or, in a sign of potential despair or resignation, use no treatment at all (28%). This behavior highlights a broader pattern of self-directed care, where consumer health products, aesthetic services, and advice from telehealth platforms or social media play a central role. These choices, driven by factors ranging from high costs and access barriers to dissatisfaction with previous treatments, are almost never captured in the data that pharmaceutical companies and health systems use to make critical decisions.

A New Lens on Real-World Health

To bridge this knowledge gap, Evidation has launched a new interactive dermatology cohort, a continuously engaged group of more than 100,000 individuals living with conditions like atopic dermatitis, psoriasis, and acne. This initiative moves beyond traditional data sources to build a more complete, dynamic picture of health as it is actually lived.

Leveraging its direct-from-participant model, the company integrates a rich variety of multimodal data. This includes not only patient-reported experiences and symptoms but also participant-captured images of their skin conditions over time, medication logs spanning both prescription and OTC products, data from wearable devices tracking sleep and activity, and permissioned clinical and claims records. By weaving these disparate threads together, the platform aims to show how conditions are managed both within and outside formal clinical settings.

This approach stands in contrast to conventional research that relies on episodic data from clinic visits. Evidation's longitudinal method captures the day-to-day fluctuations of a condition and the myriad factors that influence a patient's decisions. It’s a methodology built on a foundation of participant trust and privacy, essential for gathering such personal information.

“Dermatology is quite unique because it sits at the intersection of clinical care, consumer health, and everyday behavior,” said Leslie Oley Wilberforce, CEO of Evidation, in the company's announcement. “By capturing how people actually experience and manage their conditions over time, we can view skin health beyond an isolated concern and connect it to whole-person health.”

Reshaping Research and Consumer Health

The implications of this richer, real-world data are profound for both the pharmaceutical and consumer health industries. For life sciences companies, these insights offer a powerful tool to accelerate and de-risk drug development. Understanding why patients abandon prescriptions, how they combine therapies, or what triggers their flare-ups in the real world can lead to more effective clinical trials, better patient support programs, and stronger evidence to demonstrate a drug's value to payers.

With a history of collaborating with most of the top life sciences firms, Evidation is positioning this dermatology cohort as a critical resource for R&D. The ability to observe real-world treatment patterns can help identify unmet needs and refine therapeutic strategies for a patient population that is clearly not being fully served by the current standard of care.

Simultaneously, the findings are a goldmine for the consumer health industry. The data confirms that a massive market of self-managing patients relies heavily on accessible, non-prescription solutions. For brands selling everything from moisturizers and cleansers to specialized OTC remedies, understanding the why behind a consumer's choice is paramount. Evidation's data promises to illuminate the pain points, desired outcomes, and daily routines that drive purchasing decisions, enabling brands to develop more effective products and more resonant marketing.

Connecting Skin to Whole-Person Health

Perhaps the most significant long-term impact of this research is its push to reframe skin health as an integral part of 'whole-person health.' Chronic skin conditions are not just skin deep. They are strongly linked to mental and emotional well-being, with studies consistently showing higher rates of anxiety, stress, and depression among those affected. The visibility of these conditions can impact social interaction, sleep, and overall quality of life.

By capturing data on activity, sleep, and patient-reported mental states alongside images of skin flare-ups, Evidation’s platform can begin to quantify these complex interactions. This holistic view is critical for developing integrated care models that treat the patient, not just the symptom. It provides the evidence needed to argue for care pathways that include mental health support, stress management, and lifestyle coaching alongside dermatological treatments.

As the healthcare industry continues its shift toward data-driven, personalized medicine, understanding the complete, real-world patient experience is no longer a luxury but a necessity. Initiatives that pull back the curtain on the hidden world of self-management are not just creating better data; they are paving the way for a more empathetic, effective, and truly patient-centered approach to health.